AMT stock · ORMP stock

AMT vs ORMP

American Tower Corp (AMT) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.

American Tower Corp (AMT) is a reit - specialty company listed on US.

Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.

Latest reported AMT revenue for 2024-12-31 was $2.55B. Net income was $2.28B. Revenue was up 1.0% from 2024-09-30 to 2024-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.

Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.

AMT currently screens at market cap $90.44B and trailing P/E 31.4. ORMP currently screens at market cap $87.2M.

Not investment advice. Open the AMT and ORMP stock pages for the full models.

Not investment advice.

Popular Stock Comparisons